A clinical formulation indicated for Digestive Health. Promotes acid reduction within the stomach to assist with the management of gastrointestinal discomfort and tissue irritation.
A dual-release PPI utilized to manage acid reflux symptoms and intended to alleviate heartburn to support healing of the esophagus.
Mechanism of Action
It uses a dual delayed-release system to provide two peaks of acid suppression. It irreversibly inhibits the proton pump in stomach cells, reducing acid.
Route of Administration
Oral
Onset Time
1–3 hours (full effect 4 days)
Duration
24 hours
Contraindications
Use of rilpivirine, Severe liver disease (dosage adjust), Allergy to PPIs
Information for Dexilant is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.